COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 2668: Articles 26671-26680  | Next

How Efficacious Must a COVID-19 Coronavirus Vaccine be to Prevent or Stop an Epidemic by Itself
Bartsch, S. M., O'Shea, K. J., Ferguson, M. C., Bottazzi, M.-E., Cox, S. N., Strych, U., McKinnell, J. A., Wedlock, P. T., Siegmund, S. S., Hotez, P. J., Lee, B. Y.
10.1101/2020.05.29.20117184 — Posted: 2020-05-30
Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease
Mudd, P. A., Crawford, J. C., Turner, J. S., Souquette, A., Reynolds, D., Bender, D., Bosanquet, J. P., Anand, N. J., Striker, D. A., Martin, R. S., Boon, A. C. M., House, S. L., Remy, K. E., Hotchkiss, R. S., Presti, R. M., OHalloran, J. A., Powderly, W. G., Thomas, P. G., Ellebedy, A. H.
10.1101/2020.05.28.20115667 — Posted: 2020-05-30 Discussion: Onsite | Offsite
Future scenarios for the SARS-CoV-2 epidemic in Switzerland: an age-structured model
Estill, J., Venkova-Marchevska, P., Roelens, M., Orel, E., Temerev, A., Flahault, A., Keiser, O.
10.1101/2020.05.28.20115659 — Posted: 2020-05-30 Discussion: Offsite
Intensive COVID-19 testing associated with reduced mortality - an ecological analysis of 108 countries
Kenyon, C.
10.1101/2020.05.28.20115691 — Posted: 2020-05-30
An inflammatory cytokine signature helps predict COVID-19 severity and death
Del Valle, D. M., Kim-schulze, S., Hsin-hui, H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T., Madduri, D., Stock, A., Marron, T., Xie, H., Patel, M. K., van Oekelen, O., Rahman, A., Kovatch, P., Aberg, J., Schadt, E., Jagannath, S., Mazumdar, M., Charney, A., Firpo-Betancourt, A., Mendu, D. R., Jhang, J., Reich, D., Sigel, K., Cordon-Cardo, C., Feldmann, M., Parekh, S., Merad, M., Gnjatic, S.
10.1101/2020.05.28.20115758 — Posted: 2020-05-30 Discussion: Onsite
Pushing beyond specifications: Evaluation of linearity and clinical performance of a fully automated SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations
Nörz, D., Frontzek, A., Eigner, U., Oestereich, L., Fischer, N., Aepfelbacher, M., Pfefferle, S., Lütgehetmann, M.
10.1101/2020.05.28.20115469 — Posted: 2020-05-30
Predicting social distancing index during COVID-19 outbreak through online search engines trends
Lins Filho, P. C., Freitas, J. L. d. M., Araujo, M. M. S. d., Macedo, T. S. d., Ferreira, A. K. A., Melo, M. C. F. d., Silva, E. L. M. S. d., Caldas, A. d. F.
10.1101/2020.05.28.20115816 — Posted: 2020-05-30
Assessing the quality, readability and reliability of online information on COVID-19: aninfoveillance observational study
Lins Filho, P. C., Macedo, T. S. d., Ferreira, A. K. A., Melo, M. C. F. d., Araujo, M. M. S. d., Freitas, J. L. d. M., Caldas, T. U., Caldas, A. d. F.
10.1101/2020.05.30.20117614 — Posted: 2020-05-30
Validation and Performance Comparison of Three SARS-CoV-2 Antibody Assays
Lu, S., Paiva, K. J., Grisson, R. D., Chan, P. A., Lonks, J., King, E., Huard, R. C., Pytel-Parenteau, D. L., Nam, G. H., Yakirevich, E.
10.1101/2020.05.29.124776 — Posted: 2020-05-30
Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes
Hsieh, C.-L., Goldsmith, J. A., Schaub, J. M., DiVenere, A. M., Kuo, H.-C., Javanmardi, K., Le, K. C., Wrapp, D., Lee, A. G.-W., Liu, Y., Chou, C.-W., Byrne, P. O., Hjorth, C. K., Johnson, N. V., Ludes-Meyers, J., Nguyen, A. W., Park, J., Wang, N., Dzifa, A., Maynard, J. A., Finkelstein, I. J., McLellan, J. S.
10.1101/2020.05.30.125484 — Posted: 2020-05-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).